# Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

> **NCT06373016** · NA · RECRUITING · sponsor: **Stony Brook University** · enrollment: 100 (estimated)

## Conditions studied

- Bipolar Disorder
- Bipolar Disorder Type 1

## Interventions

- **DIETARY_SUPPLEMENT:** Glucose
- **DIETARY_SUPPLEMENT:** Ketones

## Key facts

- **NCT ID:** NCT06373016
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-26
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06373016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06373016, "Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06373016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*